Voltar
Artigo
BIBTEX RIS

Chemotherapy of Hodgkin’s lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group

1989; Humana Press; Volume: 6; Issue: 2 Linguagem: Inglês

10.1007/bf02985239

ISSN

0736-0118

Autores

Volker Diehl, Michael Pfreundschuh, Markus Löffler, U Rühl, Erhard Hiller, H Gerhartz, W. Wilmanns, Hartmut Kirchner, W. D. Schoppe, S. Petsch, H. Bartels, Karl-Heinz Pflüger, J. V. Teichmann, Roland J. Fuchs, G. Kühn, W. H. Oertel, Roland Mertelsmann, Th. Hecht, K.P. Schalk, P. Worst, M. Wilhelmy, W. Gaßmann, U. Loos, R. Hinterberger, H. Theml, Thomas Wagner, S. Samandari, W. Schäfgen, J. Preiß, G. Schmitz, Wolfgang Mende, B. Mödder, H. D. Schick,

Tópico(s)

Chronic Lymphocytic Leukemia Research

Referência(s)